Pharming Group N.V.
PHARM.AS · AMS
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | €132 | €92 | €60 | €55 |
| Short-Term Investments | €34 | €34 | €47 | €113 |
| Receivables | €44 | €53 | €47 | €50 |
| Inventory | €67 | €64 | €59 | €56 |
| Other Curr. Assets | €1 | €3 | €0 | €0 |
| Total Curr. Assets | €278 | €246 | €214 | €278 |
| Property Plant & Equip (Net) | €25 | €25 | €24 | €24 |
| Goodwill | €0 | €0 | €0 | €0 |
| Intangibles | €0 | €53 | €47 | €61 |
| Long-Term Investments | €7 | €7 | €6 | €4 |
| Tax Assets | €27 | €31 | €18 | €31 |
| Other NC Assets | €2 | €2 | €2 | €2 |
| Total NC Assets | €196 | €200 | €189 | €122 |
| Other Assets | €0 | €0 | €0 | €0 |
| Total Assets | €474 | €446 | €403 | €400 |
| Liabilities | – | – | – | – |
| Payables | €78 | €78 | €69 | €10 |
| Short-Term Debt | €5 | €5 | €5 | €4 |
| Tax Payable | €0 | €0 | €0 | €3 |
| Deferred Revenue | €0 | €0 | €0 | €0 |
| Other Curr. Liab. | -€0 | €0 | €0 | €0 |
| Total Curr. Liab. | €88 | €88 | €78 | €74 |
| LT Debt | €93 | €91 | €84 | €78 |
| Deferred Rev, NC | €0 | €0 | €0 | €0 |
| Deferred Tax Liab, NC | €0 | €0 | €0 | €0 |
| Other NC Liab. | -€0 | €0 | €0 | €0 |
| Total NC Liab. | €121 | €119 | €110 | €105 |
| Other Liabilities | €0 | €0 | €0 | €0 |
| Cap. Leases | €33 | €32 | €31 | €30 |
| Total Liabilities | €209 | €207 | €188 | €179 |
| Equity | – | – | – | – |
| Pref Stock | €0 | €0 | €0 | €0 |
| Common Stock | €8 | €8 | €8 | €8 |
| Retained Earnings | -€277 | -€286 | -€293 | -€275 |
| AOCI | €26 | €26 | €9 | -€0 |
| Other Equity | €0 | €0 | €0 | €0 |
| Total Equity | €265 | €240 | €214 | €221 |
| Supplemental Information | – | – | – | – |
| Minority Interest | €0 | €0 | €1 | €0 |
| Total Liab. & Tot. Equity | €474 | €446 | €403 | €400 |
| Net Debt | -€34 | €4 | €28 | €27 |